Whiting Samuel 4
4 · Tempest Therapeutics, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Whiting Samuel
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-02+270,000→ 270,000 totalExercise: $0.86Exp: 2035-01-01→ Common Stock (270,000 underlying)
Footnotes (1)
- [F1]These stock options vest in a series of 48 equal monthly installments measured from January 2, 2025, subject to the Reporting Person's continued service.